Machine learning methods to predict amyloid positivity using domain scores from cognitive tests

Abstract Amyloid- $$\beta$$ β (A $$\beta$$ β ) is the target in many clinical trials for Alzheimer’s disease (AD). Preclinical AD patients are heterogeneous with regards to different backgrounds and diagnosis. Accurately predicting A $$\beta$$ β status of participants by using machine learning (ML)...

Full description

Saved in:
Bibliographic Details
Main Authors: Guogen Shan, Charles Bernick, Jessica Z. K. Caldwell, Aaron Ritter
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/ea894322e2e844929f1099088cdfa50c
Tags: Add Tag
No Tags, Be the first to tag this record!